Islet autoantibodies, nationality and gender: A multinational screening study in first-degree relatives of patients with Type I diabetes

Diabetologia

Volumn 45, Issue 2, 2002, Pages 217-223

  Williams, A J K ^a   Bingley, P J ^a   Moore, W P T ^a   Gale, Edwin A M ^a   Schober, E ^a   Rami, B ^a   Bartsocas, C ^a   Gerasimidou Vazeou, A ^a   Thymelli, I ^a   Gyorko, M ^a   Madacsy, L ^a   Luczay, A ^a   Bornemisza, B ^a   Soltesz, G ^a   Joner, G ^a   Skjold Rningen, K ^a   Dahl Jrgensen, K ^a   Kinalska, I ^a   Dziatkowiak, H ^a   Wasikowa, R ^a   Kielczewska Mrozikiewicz, D ^a   Mrozikiewicz, A ^a   Schwartz, E ^a   Vaykhonsky, Y ^a   Satman, I ^a   Yilmaz, M T ^a   Yillar, G ^a   Darcan, S ^a   Osar, Z ^a   Carson, D ^a   McGlone, O ^a   Greene, S ^a   Wilson, A ^a   Robertson, K ^a   more..

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

GAD; Gender; IA 2 autoantibodies; ICA; Insulin; Nationality; Prediction; Type I diabetes

Indexed keywords

AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; AGE; AUSTRIA; AUTOIMMUNITY; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; EUROPE; FEMALE; GENDER; GREECE; HUMAN; HUNGARY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NORWAY; POLAND; PREVALENCE; PRIORITY JOURNAL; RELATIVE; RUSSIAN FEDERATION; SEX RATIO; TURKEY (REPUBLIC); UNITED KINGDOM;

ADOLESCENT; ADULT; AGE FACTORS; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EUROPE; FAMILY; FEMALE; HUMANS; INCIDENCE; ISLETS OF LANGERHANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; SEX CHARACTERISTICS;

EID: 0036186536     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-001-0749-6     Document Type: Article

References (23)

1. Optimized autoantibody-based risk assessment in family members
2. Theory and practice of nicotinamide trials in pre-type 1 diabetes
3. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial -Type 1
4. Variation and trends in incidence of childhood diabetes in Europe
5. Islet-cell antibodies in diabetes mellitus with polyendocrine disease
6. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes
7. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial islet autoantibody workshop
8. Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers
9. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40 K autoantigen and a target of islet-cell antibodies
10. GADIA2-combi determination as first line screening for improved prediction of type 1 diabetes in relatives
11. 65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test
12. A comparison of the prevalence of islet autoantibodies in children from two countries with differing incidence of diabetes
13. A novel micro-assay for insulin autoantibodies
14. Insulin and islet cell autoantibodies as time-dependent covariates in the development of insulin-dependent diabetes: A prospective study in relatives
15. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA positive relatives
16. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes
17. Diabetes and gender
18. Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: Possible relation to increased body mass index
19. Early environmental events as a cause of IDDM (evidence and implications)
20. Antiislet autoantibodies usually develop sequentially rather than simultaneously
21. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes. The 2-year analysis of the German BABYDIAB study
22. Familial risk of Type I diabetes in European children